Načítá se...
DDIS-10. ENGINEERED EXOSOMES FOR GLIOMA THERAPY
Glioblastoma (GBM) is the most common among all malignant brain tumors, with 17,000 diagnoses every year in the United States. Despite receiving surgery, radiotherapy, and chemotherapy, the median survival of GBM patients is only 14.6 months, and less than 10% of GBM patients survive more than 5 yea...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216546/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.289 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|